MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pan.2026.04.007

Медицинская библиотека · Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2026

Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal adenocarcinoma.

Siegel Niels, Stollmayer Robert, Mayer Philipp, Altendorf Natalie, Rompen Ingmar F, König Anna-Katharina, Al-Saeedi Mohammed, Loos Martin, Büchler Markus W, Klauss Miriam, Hank Thomas

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Sarcopenia and altered body composition are increasingly recognized as prognostic markers in oncology. In pancreatic ductal adenocarcinoma (PDAC), their time-dependent impact on survival remains unclear.

METHODS

Patients with PDAC who underwent resection at Heidelberg University Hospital between 2013 and 2018 were included. Preoperative CT scans were assessed at the L3 level using the automated Body and Organ Analysis (BOA) tool. Sarcopenia Index (SI) and Myosteatosis Fat Index (MFI) were calculated. Multivariable Cox regression was performed for overall survival at predefined postoperative time points.

RESULTS

A total of 723 patients were included. Some 140 patients (19.4%) underwent neoadjuvant therapy, while 583 (80.6%) received upfront surgical resection. The median OS for the entire cohort was 26.0 months (95% CI, 23.4 - 28.3). Patients with a low SI exhibited markedly reduced overall survival compared to those with a high SI (p < 0.001). In multivariate Cox regression analyses, a lower SI was independently associated with increased mortality at 90 days (HR: 0.44, 95% CI: 0.24-0.81) and at 1 year (HR: 0.71, 95% CI: 0.56-0.90). A similar prognostic pattern was observed for the MFI, which also showed independent associations with early mortality. Beyond the first postoperative year, this effect diminished and nodal status, resection margin and CA19-9 levels became the predominant predictors of overall survival.

CONCLUSIONS

Preoperative sarcopenia and myosteatosis are strong predictors of early mortality after PDAC resection, whereas tumor biology determines long-term outcomes. Automated CT-based body composition analysis may support perioperative risk stratification and targeted prehabilitation strategies.

Для цитирования: Siegel Niels, Stollmayer Robert, Mayer Philipp, Altendorf Natalie, Rompen Ingmar F, König Anna-Katharina, Al-Saeedi Mohammed, Loos Martin, Büchler Markus W, Klauss Miriam, Hank Thomas. Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal adenocarcinoma.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2026. DOI: 10.1016/j.pan.2026.04.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.